Pharmocann Global Ltd. Logo

Pharmocann Global Ltd.

Develops pharma-grade medical cannabis products like oils, ointments, tablets, and cosmetics.

PMCN-M | TA

Overview

Corporate Details

ISIN(s):
IL0010968902
LEI:
Country:
Israel
Address:
Horesh Haalonim 1, 3009500 Ramat Yishai
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Blue Wave Water Capital Ltd., formerly known as Pharmocann Global Ltd., is a publicly traded company with over 14 years of experience in the medical cannabis industry. The company has historically specialized in the development and production of pharma-grade medical cannabis products, including oils, ointments, tablets, and inhalers, as well as hemp-based cosmetics and seed oils. A recent corporate decision resulted in a name change and a strategic shift, with the company now operating as Blue Wave Water Capital Ltd.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-04 19:38
Regulatory News Service
The sector classification of BLUE WAVE WATER CAPITAL will be changed, as of Au…
English 99.3 KB
2025-02-17 18:43
Regulatory News Service
Changes in the company's name and security, effective as of February 19, 2025
Hebrew (modern) 118.3 KB
2023-10-03 16:36
Regulatory News Service
Excellence will cease to operate as a market maker in the company's shares as o…
Hebrew (modern) 118.8 KB
2020-08-23 11:39
Investor Presentation
Investors Presentation - August 2020
English 20.2 MB
2020-08-23 11:39
Registration Form
Investors Presentation - August 2020
Russian 42.3 KB

Automate Your Workflow. Get a real-time feed of all Pharmocann Global Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmocann Global Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmocann Global Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.